Table 4.
HIV prevalences in HIV indicator conditions stratified by gender.
| HIV indicator condition | Malea |
Femalea |
||
|---|---|---|---|---|
| Sample size | HIV prevalence in % (95%-CI) | Sample size | HIV prevalence in % (95%-CI) | |
| Pneumocystosis | 397 | 51.13 (46.35–55.92) | 218 | 20.64 (15.6–26.15) |
| Oral hairy leukoplakia | 86 | 52.33 (41.86–62.79) | 72 | 18.06 (9.72–27.78) |
| Kaposi's sarcoma | 699 | 39.34 (35.77–43.06) | 299 | 7.69 (4.68–11.04) |
| Syphilis | 7658 | 18.7 (17.85–19.56) | 5281 | 1.04 (0.78–1.33) |
| Gonococcal infection | 3532 | 11.66 (10.62–12.74) | 2773 | 0.87 (0.54–1.23) |
| Acute hepatitis C | 5383 | 3.9 (3.4–4.42) | 3745 | 2.03 (1.58–2.48) |
| Malignant neoplasm of anus and anal canal | 1806 | 7.14 (5.98–8.31) | 2985 | 0.4 (0.2–0.64) |
| Chronic viral hepatitis | 5431 | 3.81 (3.31–4.33) | 4189 | 1.79 (1.41–2.22) |
| Anogenital (venereal) warts | 3487 | 4.59 (3.9–5.28) | 2774 | 0.68 (0.4–1.01) |
| Chlamydial infection | 1855 | 7.06 (5.88–8.25) | 4165 | 0.1 (0.02–0.19) |
| Acute hepatitis B | 5049 | 2.32 (1.92–2.75) | 4926 | 0.99 (0.73–1.28) |
| Papillomavirus as the cause of diseases | 166 | 21.69 (15.66–28.31) | 3721 | 0.75 (0.48–1.05) |
| Tuberculosis | 8271 | 2.01 (1.72–2.31) | 8836 | 1.15 (0.94–1.38) |
| Hodgkin's lymphoma | 4010 | 1.87 (1.47–2.29) | 3971 | 0.38 (0.2–0.58) |
| Acute hepatitis A | 4296 | 1.61 (1.23–2) | 4794 | 0.6 (0.4–0.83) |
| Pneumonia | 12,533 | 1.22 (1.03–1.42) | 11,480 | 0.57 (0.44–0.71) |
| Non-Hodgkin's lymphoma | 11,444 | 0.81 (0.66–0.98) | 11,827 | 0.26 (0.18–0.36) |
| Infectious mononucleosis | 2654 | 0.79 (0.49–1.13) | 4204 | 0.14 (0.05–0.26) |
| Herpes simplex infections | 1764 | 0.91 (0.51–1.36) | 4113 | 0.17 (0.05–0.32) |
| Abnormal weight loss | 1571 | 0.76 (0.38–1.21) | 2691 | 0.15 (0.04–0.3) |
| Candidiasis | 848 | 1.53 (0.71–2.36) | 4298 | 0.12 (0.02–0.23) |
| Herpes zoster | 1686 | 0.59 (0.24–1.01) | 2949 | 0.2 (0.07–0.37) |
| Dysplasia/malignant neoplasm of cervix uteri | <50b | – | 14,490 | 0.26 (0.18–0.35) |
| Trichomoniasis | 968 | 0.52 (0.1–1.03) | 5544 | 0.22 (0.11–0.34) |
| Malignant neoplasm of bronchus and lung | 1421 | 0.35 (0.07–0.7) | 1046 | 0.1 (0–0.29) |
| Seborrheic dermatitis | 3222 | 0.4 (0.22–0.62) | 3007 | 0.03 (0–0.1) |
a
As registered at the insurance institution, the patient has the possibility to change the data.
b
This group might include transgender men with a cervix uteri. However, the sample size was too small for an investigation of HIV prevalence.